PMID- 19710242 OWN - NLM STAT- MEDLINE DCOM- 20091117 LR - 20161125 IS - 1522-1466 (Electronic) IS - 1522-1466 (Linking) VI - 297 IP - 5 DP - 2009 Nov TI - Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. PG - F1381-90 LID - 10.1152/ajprenal.00101.2009 [doi] AB - Previous studies have shown that mineralocorticoid receptor (MCR) blocker reduces proteinuria in diabetic nephropathy (DN), but the role of aldosterone in podocyte injury has never been explored in DN. This study was undertaken to elucidate whether a local aldosterone system existed in podocytes and to examine its role in podocyte apoptosis under diabetic conditions. In vitro, immortalized podocytes were exposed to 5.6 mM glucose (NG), NG + 24.4 mM mannitol, and 30 mM glucose (HG) with or without 10(-7) M spironolactone (SPR). In vivo, 32 Sprague-Dawley rats were injected with diluent (C, n = 16) or streptozotocin intraperitoneally [diabetes mellitus (DM), n = 16], and 8 rats from each group were treated with SPR for 3 mo. Aldosterone synthase (CYP11B2) and MCR mRNA and protein expression were determined by real-time PCR and Western blot, respectively, and aldosterone levels by radioimmunoassay. Western blot for apoptosis-related molecules, Hoechst 33342 staining, and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay were performed to determine apoptosis. CYP11B2 and MCR expression were significantly higher in HG-stimulated podocytes and DM glomeruli compared with NG cells and C glomeruli, respectively, along with increased aldosterone levels. Western blot analysis revealed that cleaved caspase-3 and Bax expression was significantly increased, whereas Bcl-2 expression was significantly decreased in HG-stimulated podocytes and in DM glomeruli. Apoptosis determined by Hoechst 33342 staining and TUNEL assay were also significantly increased in podocytes under diabetic conditions. These changes in the expression of apoptosis-related proteins and the increase in apoptotic cells were inhibited by SPR treatment. These findings suggest that a local aldosterone system is activated and is involved in podocyte apoptosis under diabetic conditions. FAU - Lee, Sun Ha AU - Lee SH AD - Department of Internal Medicine, College of Medicine, Brain Korea 21 for Medical Science, Yonsei University, Seoul, Korea. FAU - Yoo, Tae-Hyun AU - Yoo TH FAU - Nam, Bo-Young AU - Nam BY FAU - Kim, Dong Ki AU - Kim DK FAU - Li, Jin Ji AU - Li JJ FAU - Jung, Dong-Sub AU - Jung DS FAU - Kwak, Seung-Jae AU - Kwak SJ FAU - Ryu, Dong-Ryeol AU - Ryu DR FAU - Han, Seung Hyeok AU - Han SH FAU - Lee, Jung Eun AU - Lee JE FAU - Moon, Sung Jin AU - Moon SJ FAU - Han, Dae Suk AU - Han DS FAU - Kang, Shin-Wook AU - Kang SW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090826 PL - United States TA - Am J Physiol Renal Physiol JT - American journal of physiology. Renal physiology JID - 100901990 RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (Benzimidazoles) RN - 0 (Fluorescent Dyes) RN - 0 (Receptors, Mineralocorticoid) RN - 4964P6T9RB (Aldosterone) RN - EC 1.1.1.146 (11-beta-Hydroxysteroid Dehydrogenase Type 2) RN - EC 1.14.15.4 (Cytochrome P-450 CYP11B2) RN - EC 3.4.22.- (Caspase 3) RN - P976261J69 (bisbenzimide ethoxide trihydrochloride) SB - IM MH - 11-beta-Hydroxysteroid Dehydrogenase Type 2/biosynthesis/genetics MH - Aldosterone/*physiology MH - Animals MH - Apoptosis/*physiology MH - Apoptosis Regulatory Proteins/biosynthesis/genetics MH - Benzimidazoles MH - Blotting, Western MH - Caspase 3/biosynthesis/genetics MH - Cell Count MH - Cells, Cultured MH - Cytochrome P-450 CYP11B2/biosynthesis/genetics MH - Diabetes Mellitus, Experimental/*pathology MH - Fluorescent Antibody Technique MH - Fluorescent Dyes MH - In Situ Nick-End Labeling MH - Kidney/pathology MH - Kidney Glomerulus/metabolism MH - Male MH - Podocytes/*physiology MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Mineralocorticoid/biosynthesis/genetics MH - Reverse Transcriptase Polymerase Chain Reaction EDAT- 2009/08/28 09:00 MHDA- 2009/11/18 06:00 CRDT- 2009/08/28 09:00 PHST- 2009/08/28 09:00 [entrez] PHST- 2009/08/28 09:00 [pubmed] PHST- 2009/11/18 06:00 [medline] AID - 00101.2009 [pii] AID - 10.1152/ajprenal.00101.2009 [doi] PST - ppublish SO - Am J Physiol Renal Physiol. 2009 Nov;297(5):F1381-90. doi: 10.1152/ajprenal.00101.2009. Epub 2009 Aug 26.